Abstract
The development of new molecules is the main approach to work around the serious problem of bacterial resistance to antibiotics. The use of antimicrobial peptides (AMPs) has been an interesting and current area of research because these molecules are not considered drugs and generally do not generate or generate low resistance. Tuberculosis (TB) is a communicable infectious disease caused…